1. Home
  2. GBIO vs FCCO Comparison

GBIO vs FCCO Comparison

Compare GBIO & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FCCO
  • Stock Information
  • Founded
  • GBIO 2016
  • FCCO 1994
  • Country
  • GBIO United States
  • FCCO United States
  • Employees
  • GBIO N/A
  • FCCO N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FCCO Major Banks
  • Sector
  • GBIO Health Care
  • FCCO Finance
  • Exchange
  • GBIO Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • GBIO 29.5M
  • FCCO 190.8M
  • IPO Year
  • GBIO 2020
  • FCCO 1998
  • Fundamental
  • Price
  • GBIO $5.59
  • FCCO $28.10
  • Analyst Decision
  • GBIO Buy
  • FCCO Strong Buy
  • Analyst Count
  • GBIO 4
  • FCCO 2
  • Target Price
  • GBIO $10.67
  • FCCO $30.00
  • AVG Volume (30 Days)
  • GBIO 82.5K
  • FCCO 20.6K
  • Earning Date
  • GBIO 11-05-2025
  • FCCO 10-22-2025
  • Dividend Yield
  • GBIO N/A
  • FCCO 2.29%
  • EPS Growth
  • GBIO N/A
  • FCCO 57.01
  • EPS
  • GBIO N/A
  • FCCO 2.23
  • Revenue
  • GBIO $21,230,000.00
  • FCCO $71,913,000.00
  • Revenue This Year
  • GBIO N/A
  • FCCO $21.83
  • Revenue Next Year
  • GBIO N/A
  • FCCO $28.41
  • P/E Ratio
  • GBIO N/A
  • FCCO $12.56
  • Revenue Growth
  • GBIO 61.15
  • FCCO 21.39
  • 52 Week Low
  • GBIO $3.00
  • FCCO $19.46
  • 52 Week High
  • GBIO $29.10
  • FCCO $28.77
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 47.74
  • FCCO 72.35
  • Support Level
  • GBIO $5.63
  • FCCO $27.08
  • Resistance Level
  • GBIO $6.25
  • FCCO $28.77
  • Average True Range (ATR)
  • GBIO 0.32
  • FCCO 0.43
  • MACD
  • GBIO -0.11
  • FCCO 0.02
  • Stochastic Oscillator
  • GBIO 7.29
  • FCCO 64.74

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: